Bg Medicine Inc (BGMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,744 | -4,348 | -2,179 | -15,849 | -13,914 |
| Depreciation Amortization | 100 | 67 | 33 | 165 | 236 |
| Accounts receivable | 65 | -34 | -104 | 76 | -56 |
| Other Working Capital | -1,106 | -1,207 | -470 | -1,367 | -476 |
| Other Operating Activity | 588 | 530 | 341 | 1,687 | 1,390 |
| Operating Cash Flow | $-7,097 | $-4,992 | $-2,379 | $-15,288 | $-12,820 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -32 | -15 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $-32 | $-15 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -3,360 | -2,240 | -1,120 | -2,533 | -1,413 |
| Common Stock Issued | 9,262 | 9,262 | 1 | 13,107 | 13,840 |
| Other Financing Activity | -243 | -243 | 0 | -289 | -1,029 |
| Financing Cash Flow | $5,659 | $6,779 | $-1,119 | $10,285 | $11,398 |
| Beginning Cash Position | 7,751 | 7,751 | 7,751 | 12,786 | 12,786 |
| End Cash Position | 6,313 | 9,538 | 4,253 | 7,751 | 11,349 |
| Net Cash Flow | $-1,438 | $1,787 | $-3,498 | $-5,035 | $-1,437 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,097 | -4,992 | -2,379 | -15,288 | -12,820 |
| Capital Expenditure | N/A | N/A | N/A | -132 | -115 |
| Free Cash Flow | -7,097 | -4,992 | -2,379 | -15,420 | -12,935 |